Logo image of ALIMP.PA

IMPLANET (ALIMP.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALIMP - FR0013470168 - Common Stock

0.213 EUR
0 (0%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

0

ALIMP gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. ALIMP has a bad profitability rating. Also its financial health evaluation is rather negative. ALIMP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALIMP had negative earnings in the past year.
ALIMP had a negative operating cash flow in the past year.
ALIMP had negative earnings in each of the past 5 years.
In the past 5 years ALIMP always reported negative operating cash flow.
ALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

ALIMP has a worse Return On Assets (-28.29%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -28.29%
ROE N/A
ROIC N/A
ROA(3y)-38.11%
ROA(5y)-35.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMP.PA Yearly ROA, ROE, ROICALIMP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

ALIMP has a Gross Margin of 52.11%. This is in the lower half of the industry: ALIMP underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of ALIMP has remained more or less at the same level.
ALIMP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
ALIMP.PA Yearly Profit, Operating, Gross MarginsALIMP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ALIMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALIMP has more shares outstanding
Compared to 5 years ago, ALIMP has more shares outstanding
The debt/assets ratio for ALIMP has been reduced compared to a year ago.
ALIMP.PA Yearly Shares OutstandingALIMP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALIMP.PA Yearly Total Debt VS Total AssetsALIMP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ALIMP has an Altman-Z score of 0.05. This is a bad value and indicates that ALIMP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.05, ALIMP is doing worse than 73.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC6.99%
ALIMP.PA Yearly LT Debt VS Equity VS FCFALIMP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.75 indicates that ALIMP may have some problems paying its short term obligations.
ALIMP's Current ratio of 0.75 is on the low side compared to the rest of the industry. ALIMP is outperformed by 89.23% of its industry peers.
A Quick Ratio of 0.27 indicates that ALIMP may have some problems paying its short term obligations.
With a Quick ratio value of 0.27, ALIMP is not doing good in the industry: 90.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.27
ALIMP.PA Yearly Current Assets VS Current LiabilitesALIMP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.35% over the past year.
The Revenue has grown by 52.11% in the past year. This is a very strong growth!
Measured over the past years, ALIMP shows a small growth in Revenue. The Revenue has been growing by 4.89% on average per year.
EPS 1Y (TTM)69.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.79%
Revenue 1Y (TTM)52.11%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%41.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMP.PA Yearly Revenue VS EstimatesALIMP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALIMP.PA Yearly EPS VS EstimatesALIMP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALIMP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMP.PA Price Earnings VS Forward Price EarningsALIMP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMP.PA Per share dataALIMP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALIMP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

IMPLANET

EPA:ALIMP (12/19/2025, 7:00:00 PM)

0.213

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.57M
Revenue(TTM)11.10M
Net Income(TTM)-4.81M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.75
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.08
BVpS-0.01
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.11%
FCFM N/A
ROA(3y)-38.11%
ROA(5y)-35.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.23%
Cap/Sales 8.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.27
Altman-Z 0.05
F-Score4
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)21.33%
Cap/Depr(5y)17.29%
Cap/Sales(3y)4.01%
Cap/Sales(5y)3.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.11%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%41.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.27%
OCF growth 3YN/A
OCF growth 5YN/A

IMPLANET / ALIMP.PA FAQ

What is the ChartMill fundamental rating of IMPLANET (ALIMP.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALIMP.PA.


Can you provide the valuation status for IMPLANET?

ChartMill assigns a valuation rating of 0 / 10 to IMPLANET (ALIMP.PA). This can be considered as Overvalued.


What is the profitability of ALIMP stock?

IMPLANET (ALIMP.PA) has a profitability rating of 1 / 10.